.Atea Pharmaceuticals' antiviral has actually neglected one more COVID-19 trial, yet the biotech sti...
.Neurocrine Biosciences' schizophrenia system pivot has failed. The biotech was not able to reproduc...
.Sanofi has actually made an overdue entry to the radioligand party, paying 100 million euros ($ 110...
.After F2G's initial effort to get a new class of antifungal to market was hindered by the FDA, the ...
.Moderna has promised to reduce R&D investing by $1.1 billion through 2027. The selection to shri...
.Only four months after Sanofi bet $80 thousand in ahead of time cash on Key Therapeutics' losmapimo...
.Cancer company Oncternal Therapeutics is folding all its own scientific trials and also laying off ...
.Roche is actually storing out chances that its injectable weight problems possibility might inevita...
.Novo Nordisk has actually lifted the lid on a phase 1 test of its oral amylin as well as GLP-1 rece...
.Simply a few brief weeks after winning an FDA Fast Track tag for its investigational BTK degrader i...